Protein target complex
Abstract
[0001] The present invention relates to a method for labeling or targeting cells whose plasma membrane has lost integrity, such as dead cells, such as for discriminating between live cells and cells whose plasma membrane has lost integrity; to an embodiment of the method for determining one or more values of one or more parameters of cells of a biological sample; to use of the method in an assay for screening drugs for therapy such as cancer therapy; to use of the method to monitor and/or determine the effectiveness of a therapy; to an assay kit; to a complex; to the complex for use as a medicament; to the complex for use in treatment of cancer(s) and/or plaque(s) and/or regeneration and/or supporting the immune system; and, to a dead cell.
Inventors 3
- Maring, Markwin Hendrik
- Clemens W.G.M. Löwik Aachen author as filed: Löwik, Clemens Waltherus Gerardus
- Van Beek, Ermond Reijer
Inventors are linked to an Aachen author when surname and first name match exactly one author.
Applicants
- HQ Medical Netherlands B.V.
- Publiekrechtelijk rechtspersoon Academisch Ziekenhuis Leiden h.o.d.n. LUMC GBS Leiden
Cited papers 0 in the database
Non-patent literature as cited (1)
- - Levelt et al. Streptavidin-Tricolor is a Reliable Marker for Nonviable Cells Subjected to Permeabilization or Fixation. Cytometry 15: 84-86 (1994)